T
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A69.3 KBTrubion Pharmaceuticals, IncFeb 7, 3:49 PM ET·0001072613-11-000077
- 8-K49.6 KBTrubion Pharmaceuticals, IncOct 29, 9:09 AM ET·0001367644-10-000047
- 8-K36.6 KBTrubion Pharmaceuticals, IncOct 8, 5:03 PM ET·0000950123-10-092365
- 8-K31.6 KBTrubion Pharmaceuticals, IncSep 30, 4:25 PM ET·0000950123-10-090448
- SC 13G/A66.8 KBTrubion Pharmaceuticals, IncSep 27, 4:05 PM ET·0001104659-10-050053
- 46.2 KBTrubion Pharmaceuticals, IncSep 27, 4:04 PM ET·0001104659-10-050051
- SC 13G/A6.7 KBTrubion Pharmaceuticals, IncSep 10, 12:32 PM ET·0000315066-10-003311
- 8-K22.0 KBTrubion Pharmaceuticals, IncSep 8, 5:04 PM ET·0000950123-10-084614
- SC 13G/A8.4 KBTrubion Pharmaceuticals, IncAug 24, 1:31 PM ET·0001325447-10-000038
- SC 13D53.5 KBTrubion Pharmaceuticals, IncAug 23, 4:42 PM ET·0000950123-10-079964
Insiders
10Tickers
No tickers on record
Addresses
business
2401 4TH AVENUE SUITE 1050
SEATTLE, WA, 98121
mailing
2401 4TH AVENUE SUITE 1050
SEATTLE, WA, 98121